Shared more. Cited more. Safe forever.
    • advanced search
    • submit works
    • about
    • help
    • contact us
    • login
    View Item 
    •   MOspace Home
    • University of Missouri-Columbia
    • Graduate School - MU Theses and Dissertations (MU)
    • Theses and Dissertations (MU)
    • Theses (MU)
    • 2010 Theses (MU)
    • 2010 MU theses - Freely available online
    • View Item
    •   MOspace Home
    • University of Missouri-Columbia
    • Graduate School - MU Theses and Dissertations (MU)
    • Theses and Dissertations (MU)
    • Theses (MU)
    • 2010 Theses (MU)
    • 2010 MU theses - Freely available online
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    advanced searchsubmit worksabouthelpcontact us

    Browse

    All of MOspaceCommunities & CollectionsDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis SemesterThis CollectionDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis Semester

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular AuthorsStatistics by Referrer

    Development of an in-vitro model of equine corneal wound healing : pharmacologic and gene therapy modalities in the reduction of corneal fibrosis

    Buss, Dylan
    View/Open
    [PDF] research.pdf (1.387Mb)
    [PDF] public.pdf (2.855Kb)
    [PDF] short.pdf (60.22Kb)
    Date
    2010
    Format
    Thesis
    Metadata
    [+] Show full item record
    Abstract
    Objective: To establish an in vitro model for the investigation of equine corneal wound healing. To accomplish this goal, a protocol to isolate and culture equine corneal keratocytes, fibroblasts and myofibroblasts was developed. Using this model we investigated the safety and efficacy of MMC to treat corneal scarring in horses. Additionally, we determined if hybrid adeno-associated virus serotype 2/5 (AAV5) vector could effectively deliver foreign genes into the equine cornea without causing adverse side effects. Procedure: Using cell culture techniques, equine corneal keratocyte, fibroblast and myofibroblast cultures were produced. The MMC dose for the equine cornea was defined with dose-dependent trypan blue exclusion and MTT assays after applying MMC to the cultures once for 2 minutes. The efficacy of MMC to control corneal scarring in horses was determined by measuring mRNA and protein expression of corneal scarring markers ([alpha]-smooth muscle actin and F-actin) with western blotting, immunocytochemistry and/or quantitative real-time polymerase chain reactions. AAV5 vector expressing EGFP under control of hybrid cytomegalovirus (CMV) + chicken [beta]-actin (CBA) promoter was applied topically to ECF. Expression of delivered EGFP gene in ECF was quantified using fluorescent microscopy. Using DAPI staining, the total number of cells and transduction efficiency of tested AAV vector was determined. Phase contrast microscopy, trypan blue and TUNEL assays were used to determine toxicity and safety of AAV5 for ECFs. Results: Cell culture techniques were successfully used to establish a method for the isolation and culture of equine corneal keratocytes, fibroblasts and myofibroblasts. A single 2 minute treatment of 0.02% or less MMC did not alter ECF phenotype, viability, or cellular proliferation whereas 0.05% or higher MMC doses showed mild-to-moderate cellular toxicity. The TGF[beta]1 at 1ng/ml showed significant myofibroblast formation in ECF under serum-free conditions. A single 2 minute treatment of 0.02% or less MMC did not alter ECF phenotype, viability, or cellular proliferation whereas 0.05% or higher MMC doses showed mild-to-moderate cellular toxicity. The TGF[beta]1 at 1ng/ml showed significant myofibroblast formation in ECF under serum-free conditions. A single 2 minute, 0.02% MMC treatment 24 hours (early) after TGF[beta]1 stimulation significantly reduced conversion of ECF to myofibroblasts, however, a single 0.02% MMC treatment 11 days after TGF[beta]1 stimulation showed moderate myofibroblast inhibition. Topical AAV5 application successfully transduced significant numbers of ECFs. Transduction efficiency was 13.1%.
    URI
    https://hdl.handle.net/10355/44843
    Degree
    M.S.
    Thesis Department
    Veterinary medicine and surgery (MU)
    Rights
    OpenAccess.
    This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.
    Collections
    • Veterinary Medicine and Surgery electronic theses and dissertations (MU)
    • 2010 MU theses - Freely available online

    Send Feedback
    hosted by University of Missouri Library Systems
     

     


    Send Feedback
    hosted by University of Missouri Library Systems